<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00911794</url>
  </required_header>
  <id_info>
    <org_study_id>07300</org_study_id>
    <nct_id>NCT00911794</nct_id>
  </id_info>
  <brief_title>Written Disclosure Therapy for Anxiety and Stress in Patients With Chronic Lung Disease</brief_title>
  <official_title>Pulmonary Therapy and Supplemental Written Disclosure Therapy for Chronic Lung Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Winthrop University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stony Wold-Herbert Fund, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Winthrop University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Written Disclosure Therapy (WDT) is of any
      benefit to patients with chronic lung diseases who are participating in pulmonary
      rehabilitation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic lung diseases are typically associated with impaired quality of life, stress, and
      anxiety. Written disclosure therapy (WDT) reduces stress in patients with a variety of
      chronic illnesses. We sought to determine if written disclosure therapy benefits patients
      with chronic lung diseases when it is added as a component to the pulmonary rehabilitation
      program.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dyspnea and quality of life</measure>
    <time_frame>Two-month and six-month time</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Six-minute walk distance</measure>
    <time_frame>Two-month and six-month time</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spirometry values (FEV1 and FVC)</measure>
    <time_frame>Two-month and six-month time</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Chronic Lung Diseases</condition>
  <condition>COPD</condition>
  <condition>Pulmonary Fibrosis</condition>
  <arm_group>
    <arm_group_label>Written Disclosure Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Disclosure Writing (Written Disclosure Therapy)</intervention_name>
    <description>Patients write about a stressful life experience</description>
    <arm_group_label>Written Disclosure Therapy</arm_group_label>
    <other_name>Written Disclosure Therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neutral (Sham) Writing</intervention_name>
    <description>Patients write about neutral subjects</description>
    <arm_group_label>Controls</arm_group_label>
    <other_name>Sham Writing (Controls that wrote about neutral subjects)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of COPD or Pulmonary Fibrosis

          -  First time participants in Pulmonary Rehabilitation program

        Exclusion Criteria:

          -  Dementia

          -  Prior significant psychiatric illness

          -  Inability to complete the questionnaires

          -  Inability cooperate with spirometry

          -  Inability or to participate in outpatient follow-up over the six-month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam Hurewitz, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Winthrop University Hospital</affiliation>
  </overall_official>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 29, 2009</study_first_submitted>
  <study_first_submitted_qc>June 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2009</study_first_posted>
  <last_update_submitted>June 1, 2009</last_update_submitted>
  <last_update_submitted_qc>June 1, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 2, 2009</last_update_posted>
  <responsible_party>
    <name_title>Adam Hurewitz M.D.</name_title>
    <organization>Winthrop University Hospital</organization>
  </responsible_party>
  <keyword>Dyspnea</keyword>
  <keyword>Written Disclosure Therapy</keyword>
  <keyword>COPD</keyword>
  <keyword>Pulmonary Fibrosis</keyword>
  <keyword>Chronic Lung Diseases</keyword>
  <keyword>Pulmonary Rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Pulmonary Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

